RETRACTED ARTICLE: Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in oesophageal cancer cell

We, the Editors and Publisher of Journal of Enzyme Inhibition and Medicinal Chemistry, have retracted the following article:Mengru Jin, Luyao Shi, Dingyaun Zhang and Yanjing Li (2023) Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengru Jin (Author), Luyao Shi (Author), Li Wang (Author), Dingyuan Zhang (Author), Yanjing Li (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_36c72d1d52d64d65b8e189d3a6e05c6e
042 |a dc 
100 1 0 |a Mengru Jin  |e author 
700 1 0 |a Luyao Shi  |e author 
700 1 0 |a Li Wang  |e author 
700 1 0 |a Dingyuan Zhang  |e author 
700 1 0 |a Yanjing Li  |e author 
245 0 0 |a RETRACTED ARTICLE: Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in oesophageal cancer cell 
260 |b Taylor & Francis Group,   |c 2024-12-01T00:00:00Z. 
500 |a 10.1080/14756366.2023.2296695 
500 |a 1475-6374 
500 |a 1475-6366 
520 |a We, the Editors and Publisher of Journal of Enzyme Inhibition and Medicinal Chemistry, have retracted the following article:Mengru Jin, Luyao Shi, Dingyaun Zhang and Yanjing Li (2023) Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in oesophageal cancer cell, Journal of Enzyme Inhibition and Medicinal Chemistry, DOI: https://doi.org/10.1080/14756366.2023.2296695Since publication, significant concerns have been raised regarding the Western blot images, ethical oversight of the study, and the authorship of the article.When approached for an explanation, the authors provided responses to our queries and the original data but were unable to address all of the concerns raised.As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.We have been informed in our decision-making by our Editorial Policies and COPE guidelines.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as 'Retracted'. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 39, Iss 1 (2024) 
787 0 |n https://www.tandfonline.com/doi/10.1080/14756366.2023.2296695 
787 0 |n https://doaj.org/toc/1475-6366 
787 0 |n https://doaj.org/toc/1475-6374 
856 4 1 |u https://doaj.org/article/36c72d1d52d64d65b8e189d3a6e05c6e  |z Connect to this object online.